Dyne Therapeutics (DYN) Other Non-Current Assets (2020 - 2026)

Dyne Therapeutics (DYN) has 7 years of Other Non-Current Assets data on file, last reported at $15.6 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 702.73% year-over-year to $15.6 million in Q1 2026; TTM through Mar 2026 was $15.6 million, a 702.73% increase from a year earlier, with the FY2025 full-year figure at $15.6 million, up 703.3% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $15.6 million, roughly flat from $15.6 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for DYN reached as high as $15.6 million in Q4 2025 and fell as low as $1.9 million in Q1 2024.
• Historically, Other Non-Current Assets has averaged $4.5 million across 5 years, with a median of $2.3 million in 2023.
• Across the five-year window, Other Non-Current Assets declined 20.28% in 2022 and surged 703.3% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $2.3 million in 2022, then fell by 0.17% to $2.3 million in 2023, then retreated by 16.11% to $1.9 million in 2024, then jumped by 703.3% to $15.6 million in 2025, then decreased by 0.07% to $15.6 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $15.6 million in Q1 2026, $15.6 million in Q4 2025, and $15.0 million in Q3 2025.